These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32437925)

  • 21. Myasthenia gravis: antibodies to acetylcholine receptor with human and rat antigens.
    Oda K; Goto I; Kuroiwa Y; Onoue K; Ito Y
    Neurology; 1980 May; 30(5):543-6. PubMed ID: 7189261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis.
    Ostlie NS; Karachunski PI; Wang W; Monfardini C; Kronenberg M; Conti-Fine BM
    J Immunol; 2001 Apr; 166(8):4853-62. PubMed ID: 11290761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of T cell subpopulations and recombinant interleukin (IL)-2 on peripheral B cell function in patients with myasthenia gravis.
    Zhang J; Zhou WB; Wang HL; Guo SS
    Hum Antibodies; 1997; 8(2):90-4. PubMed ID: 9289393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
    Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
    JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice.
    Karachunski PI; Ostlie NS; Monfardini C; Conti-Fine BM
    J Immunol; 2000 May; 164(10):5236-44. PubMed ID: 10799884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetylcholine receptor antibody and clinical response to thymectomy in myasthenia gravis.
    Vincent A; Newsom-Davis J; Newton P; Beck N
    Neurology; 1983 Oct; 33(10):1276-82. PubMed ID: 6684222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetylcholine receptor antibody characteristics in myasthenia gravis. Fractionation of alpha-bungarotoxin binding site antibodies and their relationship to IgG subclass.
    Whiting PJ; Vincent A; Newsom-Davis J
    J Neuroimmunol; 1983 Aug; 5(1):1-9. PubMed ID: 6874919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
    Kawanami S; Tsuji R; Oda K
    Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical manifestations of acetylcholine receptor antibody positive and negative myasthenia gravis.
    Pasutharnchat N; Wacharapluesadee S; Hemachudha T
    J Med Assoc Thai; 2012 Mar; 95(3):313-9. PubMed ID: 22550827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the transcription factor ROR-γ reduces pathogenic Th17 cells in acetylcholine receptor antibody positive myasthenia gravis.
    Yi JS; Russo MA; Raja S; Massey JM; Juel VC; Shin J; Hobson-Webb LD; Gable K; Guptill JT
    Exp Neurol; 2020 Mar; 325():113146. PubMed ID: 31838097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-cell recognition of acetylcholine receptor provides a reliable means for monitoring autoimmunity to acetylcholine receptor in antibody-negative myasthenia gravis patients.
    Oshima M; Deitiker PR; Smith RG; Mosier D; Atassi MZ
    Autoimmunity; 2012 Mar; 45(2):153-60. PubMed ID: 21985279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis.
    Yi JS; Guidon A; Sparks S; Osborne R; Juel VC; Massey JM; Sanders DB; Weinhold KJ; Guptill JT
    J Autoimmun; 2014 Aug; 52():130-8. PubMed ID: 24378287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TCR V beta usage by acetylcholine receptor-specific CD4+ T cells in myasthenia gravis.
    Raju R; Navaneetham D; Protti MP; Horton RM; Hoppe BL; Howard J; Conti-Fine BM
    J Autoimmun; 1997 Apr; 10(2):203-17. PubMed ID: 9185882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-AChR-negative myasthenia gravis: clinical and immunological features.
    Evoli A; Bartoccioni E; Batocchi AP; Scuderi F; Tonali P
    Clin Invest Med; 1989 Apr; 12(2):104-9. PubMed ID: 2706833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acetylcholine receptor antibody in patients with myasthenia gravis.
    Xu XH; Zhu LP; Wu JY; Zhang SZ; Yang GZ; Ba T; Tan MX; Liu SL
    Asian Pac J Allergy Immunol; 1986 Dec; 4(2):101-5. PubMed ID: 3801096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody to acetylcholine receptor in canine and human myasthenia gravis: differential cross-reactivity with human and rabbit receptor.
    Dau PC; Yano CS; Ettinger SJ
    Neurology; 1979 Jul; 29(7):1065-8. PubMed ID: 572937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of anti-acetylcholine receptor profiles between Chinese cases of adult- and juvenile-onset myasthenia gravis using cell-based assays.
    Yan C; Zhao R; Song J; Feng X; Xi J; Luo S; Zhong H; Zhou S; Li W; Zhao C
    J Neuroimmunol; 2020 Dec; 349():577403. PubMed ID: 32992216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The T-cell repertoire in myasthenia gravis involves multiple cholinergic receptor epitopes.
    Link H; Xu ZY; Melms A; Kalbacher H; Sun JB; Wang ZY; Fredrikson S; Olsson T
    Scand J Immunol; 1992 Sep; 36(3):405-14. PubMed ID: 1381518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles of cytokines and T cells in the pathogenesis of myasthenia gravis.
    Uzawa A; Kuwabara S; Suzuki S; Imai T; Murai H; Ozawa Y; Yasuda M; Nagane Y; Utsugisawa K
    Clin Exp Immunol; 2021 Mar; 203(3):366-374. PubMed ID: 33184844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.